See discussions, stats, and author profiles for this publication at: http://www.researchgate.net/publication/262816596Cost-Utility Analysis of a PharmacotherapyFollow-Up for Elderly Nursing Home Residentsin SpainARTICLEinJOURNAL OF THE AMERICAN GERIATRICS SOCIETY JUNE 2014Impact Factor: 4.22 DOI: 10.1111/jgs.12890 Source: PubMedCITATION1DOWNLOADS32VIEWS2426 AUTHORS, INCLUDING:Francisco Jdar SnchezHospital Universitario Virgen del Roco15 PUBLICATIONS 11 CITATIONS SEE PROFILEjos martn martnUniversity of Granada41 PUBLICATIONS 58 CITATIONS SEE PROFILELeticia GarciaThe Andalusian School of Public Health24 PUBLICATIONS 22 CITATIONS SEE PROFILEAvailable from: jos martn martnRetrieved on: 23 July 2015CLINICALINVESTIGATIONSCostUtilityAnalysisofaPharmacotherapyFollow-UpforElderlyNursingHomeResidentsinSpainFranciscoJ odar-Sanchez,MSc,*JoseJ.Martn,PhD,M.PuertoL opezdelAmo,PhD,LeticiaGarca,MSc,JoseM.Ara ujo-Santos,PhD,andDavidEpstein,PhDOBJECTIVES: To compare the cost-effectiveness of apharmacotherapy follow-up for elderly nursing home(NH)residentswiththatofusualcare.DESIGN: Prospective observational studywithaconcur-rentcontrolgroupconductedover12months.SETTING: FifteenNHs inAndalusiaassignedtocontrol(n=6)orintervention(n=9).PARTICIPANTS: Residentsaged65andolder.INTERVENTION: Pharmacotherapyfollow-up.MEASUREMENTS: Negative outcomes associated withmedication, health-related quality of life, cost, quality-adjustedlife-year (QALY), andincremental cost-effective-ness ratio (ICER). ICERs were estimated for three scenarios:unadjusted cost per QALY (rst scenario), costs adjusted forbaseline prescribed medication and QALYs adjusted forbaseline utility score (second scenario), and costs andQALYsadjustedforafullerset of baselinecharacteristics(third scenario).RESULTS: Three hundred thirty-two elderly residents wereenrolled:122inthecontrolgroupand210intheinterven-tiongroup. Thegeneral practitioneraccepted88.7%(274/309)ofpharmacistrecommendations.Pharmacistinterven-tionsreducedtheaveragenumberofprescribedmedicationby0.47drugs (P